Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Questions

Are you sure that comment was about the share buyback program? I recall him saying that about the semi-annual dividend program, but not about the share buyback. I would hope that they would continue the buyback, as that serves in essence as a dividend, but increasing the share price due to reducing the float, and is a much better long term solution as it helps on the exchange listing front as well.

Share
New Message
Please login to post a reply